🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: F511 cream may prevent or reduce palmar-plantar erythrodysesthes...
Status
Completed
Location
Kantonsspital Aarau
Start Date
2009-09
Trial ID
NCT00992706
Treatments Being Tested
Cyclophosphamide is a chemotherapy agent with known activity in myeloma. Th...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2008-09
Trial ID
NCT00750815
Treatments Being Tested
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
This is a Phase 1/1b, open-label, dose-escalation, and dose-expansion study...
Status
Completed
Location
Scottsdale Healthcare Hospitals dba Honor Health Research Institute
Start Date
2018-10-15
Trial ID
NCT03719326
A Phase 3 global study comparing avelumab alone to avelumab plus PLD and to...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2015-12-21
Trial ID
NCT02580058
This is a phase II, multicenter, open label, nonrandomized study to evaluat...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2009-09
Trial ID
NCT01160484
Treatments Being Tested
This is a multicenter, open label, non-inferiority, randomized controlled c...
Status
Recruiting
Location
Sunyat-sen Memorial Hospital
Start Date
2021-12-20
Trial ID
NCT05159193
This phase II trial compares the effect of sacituzumab govitecan and bevaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07504588
This phase II/III trial studies how well trametinib works and compares it t...
Status
Completed
Location
Tennessee Valley Gynecologic Oncology
Start Date
2014-04-11
Trial ID
NCT02101788
This phase II/III trial studies how well pegylated liposomal doxorubicin hy...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2017-06-23
Trial ID
NCT02839707